Medical Center for Infectious Diseases

Medical Center for Infectious Diseases Berlin (mib) AG is a specialized medical laboratory and clinical research center based in Berlin, Germany. Led by CEO Dr. Martin Obermeier, the company focuses on advanced molecular diagnostics and the treatment of infectious diseases, particularly HIV, viral hepatitis, and sexually transmitted infections. It serves as a key clinical trial site for major pharmaceutical and diagnostic companies, including Abbott and Qiagen, and is actively involved in groundbreaking research such as HIV remission and resistance testing. The center operates as a Medizinisches Versorgungszentrum (MVZ) and provides comprehensive care and diagnostic services to patients while contributing to global clinical development programs.